Yameng Hu
- Molecular Biology
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Inorganic Chemistry top 10%
- Oncology
- Topics
- RNA modifications and cancer (7 papers)Epigenetics and DNA Methylation (4 papers)MicroRNA in disease regulation (4 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yameng Hu
20 papers receiving 774 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Molecular Biology 479
- Cancer Research 307
- Pulmonary and Respiratory Medicine 119
- Inorganic Chemistry 109
- Oncology 105
Countries citing papers authored by Yameng Hu
This map shows the geographic impact of Yameng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yameng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yameng Hu more than expected).
Fields of papers citing papers by Yameng Hu
This network shows the impact of papers produced by Yameng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yameng Hu. The network helps show where Yameng Hu may publish in the future.
Co-authorship network of co-authors of Yameng Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Yameng Hu. A scholar is included among the top collaborators of Yameng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yameng Hu. Yameng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | LPCAT1-mediated membrane phospholipid remodelling promotes ferroptosis evasion and tumour growthbreakdown → | 60 |
| 3 | 26 | |
| 4 | 7 | |
| 5 | 14 | |
| 6 | 29 | |
| 7 | 3 | |
| 8 | 32 | |
| 9 | 23 | |
| 10 | 52 | |
| 11 | 51 | |
| 12 | 138 | |
| 13 | 78 | |
| 14 | 62 | |
| 15 | 35 | |
| 16 | 30 | |
| 17 | 5 | |
| 18 | 41 | |
| 19 | 36 | |
| 20 | 45 |
About Yameng Hu
Yameng Hu is a scholar working on Cancer Research, Molecular Biology and Geochemistry and Petrology, having authored 21 papers that have together received 781 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Epigenetics and DNA Methylation (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (307 citations), Industrial and Manufacturing Engineering (82 citations) and Inorganic Chemistry (109 citations). Yameng Hu has collaborated with scholars based in China, United States and France. Frequent co-authors include Libing Song, Ziwen Li, Shuxia Zhang, Miaoling Tang, Jun Li, Ruyuan Yu, Meisongzhu Yang, Geyan Wu, Xinyi Liao and Xingui Wu. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.